Pharmacogenomics europe: design & implementation strategy of ubiquitous pharmacogenomics consortium
- At: Glasgow (Scotland) (2018)
- Type: Poster
- Poster code: POS-SAP-007
- By: CHEUNG, Ka-Chun (Royal Dutch Pharmacists Association, Medicine Information Centre)
- Co-author(s): Ka-Chun Cheung
Mandy Crommentuijn-van Rhenen: Medicine Information Centre, Royal Dutch Pharmacists Association, DEN HAAG, Netherlands
Henk-Jan Guchelaar: Clinical Pharmacy & Toxicology, Leiden University Medical Center, LEIDEN, Netherlands
Inge Holsappel: Medicine Information Centre, Royal Dutch Pharmacists Association, DEN HAAG, Netherlands
Christina Mitropoulou: The Golden Helix Foundation, LONDON, United Kingdom
Marga Nijenhuis: Medicine Information Centre, Royal Dutch Pharmacists Association, DEN HAAG, Netherlands
Matthias Samwald: Center for Medical Statistics, Informatics, and Intelligent Systems, Medical University of Vienna, VIENNA, Austria
Matthias Schwab: Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, STUTTGART, Germany;Clinical Pharmacology, University Hospital Tübingen, TUBINGEN, Germany;Pharmacy and Biochemistry, University Hospital Tübingen, TUBINGEN, Germany
Jesse Swen: Clinical Pharmacy & Toxicology, Leiden University Medical Center, LEIDEN, Netherlands - Abstract:
Background
Despite scientific and clinical advances in the field of pharmacogenomics (PGx), application into routine care remains limited. Opportunely, several implementation studies and programmes have been initiated over recent years. One research gap seen in these studies is the undetermined collective clinical utility of implementing a panel of .. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 28 September 2023